These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 12015416)

  • 1. Calcineurin and cardiac hypertrophy: where have we been? Where are we going?
    Wilkins BJ; Molkentin JD
    J Physiol; 2002 May; 541(Pt 1):1-8. PubMed ID: 12015416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes.
    Fiedler B; Lohmann SM; Smolenski A; Linnemuller S; Pieske B; Schroder F; Molkentin JD; Drexler H; Wollert KC
    Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11363-8. PubMed ID: 12177418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcineurin and hypertrophic heart disease: novel insights and remaining questions.
    Bueno OF; van Rooij E; Molkentin JD; Doevendans PA; De Windt LJ
    Cardiovasc Res; 2002 Mar; 53(4):806-21. PubMed ID: 11922891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy.
    Wilkins BJ; Dai YS; Bueno OF; Parsons SA; Xu J; Plank DM; Jones F; Kimball TR; Molkentin JD
    Circ Res; 2004 Jan; 94(1):110-8. PubMed ID: 14656927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium-calcineurin signaling in the regulation of cardiac hypertrophy.
    Wilkins BJ; Molkentin JD
    Biochem Biophys Res Commun; 2004 Oct; 322(4):1178-91. PubMed ID: 15336966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Old and new tools to dissect calcineurin's role in pressure-overload cardiac hypertrophy.
    Zhang W
    Cardiovasc Res; 2002 Feb; 53(2):294-303. PubMed ID: 11827679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remodeling muscles with calcineurin.
    Olson EN; Williams RS
    Bioessays; 2000 Jun; 22(6):510-9. PubMed ID: 10842305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of cardiac hypertrophy by intracellular signalling pathways.
    Heineke J; Molkentin JD
    Nat Rev Mol Cell Biol; 2006 Aug; 7(8):589-600. PubMed ID: 16936699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role and regulation of calcineurin-dependent signal pathway in cardiac hypertrophy of rats].
    Fu MG
    Sheng Li Ke Xue Jin Zhan; 2001 Jan; 32(1):52-4. PubMed ID: 12545778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcineurin and electrical remodeling in pathologic cardiac hypertrophy.
    Liu HB; Yang BF; Dong DL
    Trends Cardiovasc Med; 2010 Jul; 20(5):148-53. PubMed ID: 21742270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcineurin activation is not necessary for Doxorubicin-induced hypertrophy in H9c2 embryonic rat cardiac cells: involvement of the phosphoinositide 3-kinase-Akt pathway.
    Merten KE; Jiang Y; Feng W; Kang YJ
    J Pharmacol Exp Ther; 2006 Nov; 319(2):934-40. PubMed ID: 16926266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting calcineurin and associated pathways in cardiac hypertrophy and failure.
    Fiedler B; Wollert KC
    Expert Opin Ther Targets; 2005 Oct; 9(5):963-73. PubMed ID: 16185152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted inhibition of calcineurin attenuates cardiac hypertrophy in vivo.
    De Windt LJ; Lim HW; Bueno OF; Liang Q; Delling U; Braz JC; Glascock BJ; Kimball TF; del Monte F; Hajjar RJ; Molkentin JD
    Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3322-7. PubMed ID: 11248077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs.
    Molkentin JD
    Cardiovasc Res; 2004 Aug; 63(3):467-75. PubMed ID: 15276472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory molecules in signal transduction pathways of cardiac hypertrophy.
    Takano H; Zou Y; Akazawa H; Toko H; Mizukami M; Hasegawa H; Asakawa M; Nagai T; Komuro I
    Hypertens Res; 2002 Jul; 25(4):491-8. PubMed ID: 12358132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo.
    Passier R; Zeng H; Frey N; Naya FJ; Nicol RL; McKinsey TA; Overbeek P; Richardson JA; Grant SR; Olson EN
    J Clin Invest; 2000 May; 105(10):1395-406. PubMed ID: 10811847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRPC channels as effectors of cardiac hypertrophy.
    Eder P; Molkentin JD
    Circ Res; 2011 Jan; 108(2):265-72. PubMed ID: 21252153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and cellular mechanisms of mechanical stress-induced cardiac hypertrophy.
    Zou Y; Takano H; Akazawa H; Nagai T; Mizukami M; Komuro I
    Endocr J; 2002 Feb; 49(1):1-13. PubMed ID: 12008744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcineurin independent development of myocardial hypertrophy in transgenic rats overexpressing the mouse renin gene, TGR(mREN2)27.
    Diedrichs H; Mei C; Frank KF; Boelck B; Schwinger RH
    J Mol Med (Berl); 2004 Oct; 82(10):688-95. PubMed ID: 15322704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired cardiac hypertrophic response in Calcineurin Abeta -deficient mice.
    Bueno OF; Wilkins BJ; Tymitz KM; Glascock BJ; Kimball TF; Lorenz JN; Molkentin JD
    Proc Natl Acad Sci U S A; 2002 Apr; 99(7):4586-91. PubMed ID: 11904392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.